Allstate to acquire SquareTrade for about $1.4 bln

The Allstate Corp has agreed to buy San Francisco and London-based SquareTrade, a consumer protection plan provider, for about $1.4 billion. The sellers included Bain Capital Private Equity and Bain Capital Ventures. The deal is expected to close in January 2017. Ardea Partners, Lazard and Willkie Farr & Gallagher advised Allstate in the transaction while Financial Technology Partners and Ropes & Gray advised SquareTrade. PRESS RELEASE NORTHBROOK, Ill., Nov. 28, 2016 – The Allstate Corporation (NYSE: ALL) has agreed to acquire SquareTrade, a rapidly growing consumer protection plan provider that distributes through many of America’s major retailers. The privately held company will be purchased for approximately $1.4 billion from a group of shareholders, including Bain Capital Private Equity and Bain Capital Ventures, in a transaction expected to close in January 2017. “Allstate’s consumer-focused strategy of providing unique products will be further enhanced with the acquisition of
Continue reading "Allstate to acquire SquareTrade for about $1.4 bln"

Market Recap Aug 4, 2015

Listless trading continued as a plunge in Apple (AAPL) after it fell below its 200 day moving average caught most people's focus. Some comments out of a Fed member also caused some consternation but losses were mild as the S&P 500 fell 0.22% and the NASDAQ 0.19%.
The major averages briefly extended losses after Atlanta Fed President Dennis Lockhart, a voting member, told the Wall...<br/>

Read the full article at StockTradingToGo.com

Alizé Pharma III collects $1.94 mln

Alizé Pharma III SAS, a developer of biopharmaceutical products that treat metabolic disorders and rare diseases, has raised $1.94 million in funding. The investors included Sofimac Partners via their FCPI Emergence Innovation 1 seed capital fund, Octalfa, Sham Innovation Santé, Rhône-Alpes Création, Crédit Agricole Création, CEMA and TAB Consulting. PRESS RELEASE Lyon, France, March 17, 2015 – Alizé Pharma III SAS, an Alizé Pharma company specialized in the development of biopharmaceutical products to treat metabolic disorders and rare diseases, today announces that it has raised €1.8 million (USD $1.94 million) in a first financing round. The funding round was supported by a syndicate of investors that included Sofimac Partners via their FCPI Emergence Innovation 1 seed capital fund, Octalfa, Sham Innovation Santé, Rhône-Alpes Création, Crédit Agricole Création, CEMA and TAB Consulting. Alizé Pharma III will use the funds to conduct a pharmacology and lead optimization program on a family of peptides with anabolic effects on the bone. The I-HBD1 program will be performed in collaboration with Alizé Pharma III’s US partner New Paradigm Therapeutics Inc., a spin-off from the University of North Carolina at Chapel Hill founded by Dr. David Clemmons. The aim of the program is to select a drug candidate that will enter development for the treatment of osteoporosis and other diseases with impaired bone metabolism in 2016. According to the International Osteoporosis Foundation, over 200 million patients worldwide live with osteoporosis and the disease causes almost 9 million fractures each year. The global market for osteoporosis drugs was estimated at over $8.3 billion in 2014, with significant growth expected in the coming years.
Continue reading "Alizé Pharma III collects $1.94 mln"

Allstate Investments expands team with a hire and a promotion

Allstate Investments has hired Russell K. Mayerfeld as a senior managing director and promoted Peter Keehn to managing director of private equity investing. Mayerfeld is the former managing director of investment banking at UBS and its predecessors while Keehn first joined Allstate in 2003 a director to head the company’s then $450 million alternative assets portfolio. PRESS RELEASE NORTHBROOK, Ill., Oct. 14, 2014 /PRNewswire/ — The Allstate Corporation (NYSE: ALL) has expanded its senior leadership team in investments. Russell K. Mayerfeld has joined Allstate as a senior managing director, reporting to Judith P. Greffin, chief investment officer. Peter Keehn, CFA, has been promoted to managing director, private equity investing, reporting to Mayerfeld. “We expect to capture additional higher-returning investment opportunities by leveraging Russ’ leadership, broad expertise and extensive experience,” Greffin said. “We have an excellent track record, and our team is in a strong position to increase the breadth and size of Allstate’s portfolio in these asset classes.”
Russ Mayerfeld Mayerfeld oversees approximately $10 billion of Allstate’s investments, including private equity, infrastructure and real assets, real estate and commercial mortgage loans. Throughout his career, he has worked extensively with insurance companies and other financial institutions. Recently, Mayerfeld served as an independent consultant to private equity funds and corporations and as a board member for private and public companies. Mayerfeld was managing director, investment banking of UBS LLC and its predecessors from 1997 to 2003, and managing director, investment banking of Dean Witter Reynolds Inc. from 1988 to 1997. He holds an MBA from Harvard University and a bachelor’s degree from the University of Illinois. “I am delighted to join Allstate Investments,” Mayerfeld said. “I look forward to building on the success of the team to position Allstate as an even more dynamic investor in this evolving sector. We will leverage the skills and experience of our alternative investment professionals, as well as the breadth and scale of the Allstate enterprise, to source attractive opportunities. With our size, flexibility and creativity, we will continue to help our portfolio companies achieve their objectives.”
Allstate will expand its alternative investment portfolio over the next several years, with much of the growth coming from direct investments. “Allstate will continue to be a fund investor while leveraging its relationships to generate additional direct investments. Ultimately, this dual approach is designed to produce more favorable risk-adjusted returns for the benefit of Allstate’s shareholders and policyholders,” Mayerfeld said. Peter Keehn
Keehn will continue to lead Allstate’s global private equity investing group, which includes the infrastructure and real assets team, managing a portfolio of approximately $3 billion. Recently, he shifted the focus of Allstate’s private equity activities to include more direct investing and co-investments. In 2007, Keehn established Allstate’s London office to enhance the firm’s global perspective and gain greater access to investment opportunities around the world. He joined Allstate in 2003 as a director to head the company’s then $450 million alternative assets portfolio. Earlier in his career, he was a principal at Waud Capital Partners and a director at Northwestern Investment Management Co. Keehn has an MBA from Northwestern University and a bachelor’s degree from Brown University. He is a chartered financial analyst. Keehn serves on several private equity advisory boards and has been a director of numerous private companies and nonprofit organizations. “I am enthusiastic about the opportunity to continue expanding Allstate’s private equity investments and further developing the expertise of our portfolio team,” Keehn said. “We see strong opportunities throughout the world in this asset class. It’s an important component in the proactive management of Allstate’s portfolio to achieve attractive returns for the benefit of our policyholders and shareholders.” The Allstate Corporation (NYSE: ALL) is the nation’s largest publicly held personal lines insurer, protecting approximately 16 million households from life’s uncertainties through its Allstate, Encompass, Esurance and Answer Financial brand names and Allstate Financial business segment. Allstate is widely known through the slogan “You’re In Good Hands With Allstate®.” The Allstate brand’s network of small businesses offers auto, home, life and retirement products and services to customers in the United States and Canada. In 2013, The Allstate Foundation, Allstate, its employees and agency owners gave $29 million to support local communities. Allstate employees and agency owners donated 200,000 hours of service across the country.